trial · primary record
TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
Blood Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2030-06 |
| Primary endpoint | Incidence of grade III-IV acute graft-versus-host disease (GVHD) |
| Registry ID | NCT04806347 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:26.605Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04806347
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.